In the past several months, the Trump administration has frozen, cancelled, or rescinded millions—even billions—of dollars in federal funding for scientific and clinical research. This is funding that flows directly from bodies like the NIH to universities, academic medical centers, and others to facilitate basic science research, translational research, public health initiatives, and more.
Frankly, many organizations did not see these cuts coming—at least not at this scale. And the impacts are likely to touch most every corner of the industry.
This week, host Abby Burns sits down with Advisory Board experts Emily Heuser and Gaby Marmolejos to dig into how these cuts are being orchestrated and the ripple effects they may cause across—and even beyond—the healthcare industry.
We’re here to help:
Navigating healthcare’s next frontier: 5 takeaways from the CHG Healthcare Executive Summit
A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.